Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clusterrandomised, double-blind, placebo controlled trial of vitamin D supplementation for the prevention of influenza and other respiratory infections in sheltered accommodation (ViDiFlu).

Next Previous
Search
Trial Profile

Clusterrandomised, double-blind, placebo controlled trial of vitamin D supplementation for the prevention of influenza and other respiratory infections in sheltered accommodation (ViDiFlu).

Status: Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 18 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Colecalciferol
  • Indications Influenza virus infections; Respiratory tract infections
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms VidiFlu

    • Most Recent Events

    • 04 Feb 2014 Biomarkers information updated
    • 27 Jul 2012 Planned End Date changed from 30 Aug 2013 to 31 Mar 2012 as reported by United Kingdom Clinical Research Network.
    • 27 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top